BPC-157

Description

Overview

BPC-157 is positioned as a connective tissue repair peptide for recovery and performance research, with emphasis on tendons, ligaments, gut lining, nagging joint pain, and slow-to-heal tissue.

Available formats

• 5mg
• 10mg

Purchase options

• Subscription: $50.99. Ships every 30 days. Pause, skip, or cancel anytime.
• One-time purchase: $59.99. No commitment, single shipment.

Research notes

Preclinical research focuses on angiogenesis via VEGF pathways and tendon-to-bone healing, with animal models showing accelerated repair of ligament, muscle, and GI tissue.

Unlike systemic compounds, BPC-157 is typically associated in the literature with local activity at the injection site. It is structurally stable in gastric fluid, which is unusual for a peptide of its length, and is the subject of ongoing investigation for both injectable and oral formats in preclinical settings.

Protocol notes

• Once daily subcutaneous, 4-6 week cycles.
• Reconstitute with 2 mL bacteriostatic water per 5 mg vial.
• Store at 2-8°C and avoid light.
• Reconstituted vials stable for up to 30 days refrigerated.

COA and testing

Every lot ships with an independent Certificate of Analysis on file. COA format includes HPLC chromatogram, identity, endotoxin, and lot-specific documentation. Request the document for the exact lot received.

References

• Journal of Molecular Medicine: Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.
• Journal of Orthopaedic Research: Pentadecapeptide BPC 157 improves ligament healing in the rat.
• Pharmaceuticals (Basel): Tendon, ligament, and muscle injury therapy perspectives with stable gastric pentadecapeptide BPC 157.

Legal

Sold for laboratory and research purposes only. Not for human consumption. Not evaluated or approved by Health Canada for therapeutic use.